The regulatory role of semaphorin 3E in allergic asthma.
Airway hyperresponsiveness
Airway remodeling
Asthma
Inflammation
PlexinD1
Sema3E
Journal
The international journal of biochemistry & cell biology
ISSN: 1878-5875
Titre abrégé: Int J Biochem Cell Biol
Pays: Netherlands
ID NLM: 9508482
Informations de publication
Date de publication:
01 2019
01 2019
Historique:
received:
04
07
2018
revised:
06
11
2018
accepted:
12
11
2018
pubmed:
18
11
2018
medline:
19
7
2019
entrez:
18
11
2018
Statut:
ppublish
Résumé
Semaphorins were originally discovered as essential mediators involved in regulation of axonal growth during development of the nervous system. Ubiquitously expressed on various organs, they control several cellular functions by regulating essential signaling pathways. Among them, semaphorin3E binds plexinD1 as the primary receptor and mediates regulatory effects on cell migration, proliferation, and angiogenesis considered major physiological and pathological features in health and disease. Recent in vitro and in vivo experimental evidence demonstrate a key regulator role of semaphorin3E on airway inflammation, hyperresponsivenss and remodeling in allergic asthma. Herein, we aim to provide a broad overview of the biology of semaphorin family and review the recently discovered regulatory role of semaphorin3E in modulating immune cells and structural cells function in the airways. These findings support the concept of semaphorin3E/plexinD1 axis as a therapeutic target in allergic asthma.
Identifiants
pubmed: 30447428
pii: S1357-2725(18)30242-5
doi: 10.1016/j.biocel.2018.11.006
pii:
doi:
Substances chimiques
Cell Adhesion Molecules, Neuronal
0
Intracellular Signaling Peptides and Proteins
0
Membrane Glycoproteins
0
PLXND1 protein, human
0
SEMA3E protein, human
0
Semaphorins
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
68-73Subventions
Organisme : CIHR
ID : MOP # 115115
Pays : Canada
Informations de copyright
Copyright © 2018 Elsevier Ltd. All rights reserved.